Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Special Seminar: Departments of Pathology and Medicine - Professor Helen Heslop

Professor Helen Heslop

Baylor College of Medicine, Houston, Texas, USA

Cellular immunotherapies have immense potential as they can specifically target tumor antigens through native or artificial receptors. We have evaluated expanded T cells recognizing tumor antigens though their native receptor to target viruses such as EBV or HPV expressed on tumor cells with encouraging response rates when using either autologous cells or donor derived cells post transplant. More recent studies have infused closely matched third-party virus-specific T cells and reported encouraging response rates between 50 and 90%. Antigen specific T cells may also be used as target cells for transfer of artificial receptors such as chimeric antigen receptors (CARs).

Date Wednesday, 14 August 2019
Time 1:00pm - 2:00pm
Audience All University,Public
Event Category Health Sciences
Event Type Departmental Seminar
Divisional Seminar
Open Seminar
Special Lecture
CampusDunedin
DepartmentPathology (Dunedin), Medicine (Dunedin)
LocationD'ath Lecture Theatre, Hercus Building
Contact NameProf Sarah Young
Contact Emailsarah.young@otago.ac.nz

Save this event